[144] Doximity, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Doximity, Inc. (DOCS): The filer reports a proposed sale of 2,000 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $140,020.00, expected to sell on 10/01/2025 on the NYSE. The securities were acquired on 10/01/2025 by stock option exercise and paid in cash. The filing also discloses three prior sales by the same person in the past three months: 2,000 shares on 09/02/2025 for $133,140.00, 2,000 shares on 08/01/2025 for $114,180.00, and 2,000 shares on 07/01/2025 for $121,920.00. The notice includes the standard Rule 144 signature representation regarding material nonpublic information.

Positive

• None.

Negative

• Insider sales disclosed: The filer sold or proposes to sell 6,000 shares across the past three months and plans an additional 2,000-share sale, which may be viewed unfavorably by some investors.

Insights

Securities Analyst

TL;DR: Insider sold recently acquired option shares in small, routine blocks; disclosure is standard under Rule 144.

The filing shows a proposed sale of 2,000 shares acquired by stock option exercise and paid in cash, to be executed through Morgan Stanley Smith Barney on the NYSE. The seller recorded three prior monthly sales of identical size during the past three months, indicating ongoing disposals by the same person. From a trading disclosure perspective this is a routine compliance filing and does not, on its face, indicate new company-specific developments or disclosed material nonpublic information.

Corporate Governance Expert

TL;DR: Transaction appears compliant with Rule 144; multiple recent sales merit monitoring for insider disposition patterns.

The notice certifies the seller lacks undisclosed material information and provides acquisition and payment details consistent with an option exercise followed by planned sale. Repeated monthly sales of 2,000-share blocks are recorded; while fully permissible, such patterns can be relevant to governance oversight and dilution analysis. The filing itself contains the standard attestation language and broker details required for Rule 144 compliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	140020.00	187299459	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Stock Option Exercise	Issuer			2000	10/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	09/02/2025	2000	133140.00
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	08/01/2025	2000	114180.00
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	07/01/2025	2000	121920.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Form 144 for DOCS disclose?

It discloses a proposed sale of 2,000 common shares by the filer through Morgan Stanley Smith Barney with an aggregate market value of $140,020.00, plus three prior sales in the past three months.

When is the planned sale date on the DOCS Form 144?

The filing lists the approximate date of sale as 10/01/2025 and the exchange as the NYSE.

How were the shares acquired according to the filing?

The 2,000 shares were acquired via stock option exercise on 10/01/2025 and paid for in cash.

Does the filing state the seller has material nonpublic information?

No. The notice includes the standard representation that the seller does not know any material adverse information that has not been publicly disclosed.

Who is the broker handling the proposed sale?

Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004) is listed as the broker.